New cancer clinical trial: Study to Investigate the Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer Who Progressed After 2 or More HER-2 Directed Chemotherapy

Published on: November 27, 2018 at 12:00PM
Conditions:   HER2-positive Breast Cancer;   Metastatic Breast Cancer
Intervention:   Drug: Herzuma
Sponsor:   National Cancer Center, Korea
Not yet recruiting
https://ift.tt/2AxAr1M